In addition to being one of the oldest and most historically significant cities in the United States, Boston is home to world-renowned medical centers and education programs and the site of important medical milestones.
Numerous events during the annual meeting will allow members to find their home within CHEST, catch up with attendees who share similar identities and goals, and collaborate on exciting initiatives, said Margaret Pisani, MD, MPH, FCCP.
This year’s CHEST Annual Meeting will provide insight into artificial intelligence in medicine, the health impact of climate change, the vaping epidemic, and more, said CHEST President, Jack D. Buckley, MD, MPH, FCCP.
Longtime CHEST Annual Meeting attendees like Erika D. Lease, MD, FCCP, never tire of connecting with colleagues in person and sharing in the latest scientific and clinical updates.
Robust educational opportunities prior to the annual meeting will help clinicians of all experience levels review foundational knowledge and keep up with changes in the field, said CHEST Education Committee Chair, Hans Lee, MD, MEHP, FCCP.
CHEST President-Elect, John “Jack” D. Buckley, MD, MPH, FCCP, emphasized the importance of mentoring in helping the organization and its clinicians better reflect the diversity of their patients and society.
Fellows from the University of Oklahoma, the University of Southern California, and the University of Texas Health Science Center at Houston competed in creative clinical trivia and live challenges.
Deji Adegunsoye, MD, PhD, FCCP, reviewed the role of genetic testing in pulmonary fibrosis in the past, present, and future management of the disease.
Diego J. Maselli, MD, FCCP, and other experts provided updates on biologics approved in asthma and in trials for COPD.
Before leaving Honolulu, make plans with your colleagues to reconvene for CHEST 2024, October 6-9, in Boston, MA.
A Wednesday morning session, chaired by Thomas DeCato, MD, FCCP, will help clinicians navigate the current guidance for pulmonary function tests, address controversial issues, and answer unresolved questions from their daily practice.
A Wednesday morning panel discussion, chaired by Sean Callahan, MD, will help attendees distinguish incidental interstitial lung abnormalities from more consequential findings such as interstitial lung disease.